Display Settings:

Format

Send to:

Choose Destination
    Thromb Res. 2010 Jun;125(6):490-3. Epub 2010 Jan 25.

    Venous thromboembolism and prognosis in cancer.

    Source

    James P. Wilmot Cancer Center, and the Department of Medicine, University of Rochester, Rochester, NY 14642, USA. alok_khorana@URMC.rochester.edu

    Abstract

    Venous thromboembolism (VTE) is a frequent complication of malignancy, and its incidence has increased markedly in recent years. VTE itself can directly lead to patient mortality, and is the second leading cause of death in patients with cancer. Furthermore, emerging data suggest that activation of coagulation in malignancy is integrally linked with tumor biology, particularly with angiogenesis. The development of the clinical hypercoagulable state is also linked with adverse prognosis in patients with cancer, including patients receiving systemic chemotherapy. This review focuses on the clinical evidence documenting a link between VTE and adverse short-term and long-term prognosis in patients with cancer.

    Copyright 2010 Elsevier Ltd. All rights reserved.

    PMID:
    20097409
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2878879
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Figure 2
    Figure 1

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk